Skip to main content
. 2020 May 19;88:11–16. doi: 10.1016/j.bbi.2020.05.037

Table 1.

Demographic and clinical data of the whole group, also distributed for sex.

Demographic and Clinical Data Total (n = 103) Man (n = 59) Woman (n = 44) p Value
Age (Mean ± SD) 55 ± 14.65 56 ± 13.86 52.35 ± 15.64 ns
Temperature (Mean ± SD) 36 ± 0.45 36 ± 0.42 36.36 ± 0.49 ns

Inflammatory serum markers

WBC (x109/L) (Mean ± SD) 8.55 ± 6.23 9.65 ± 7.44 6.61 ± 2.15 0.0082
Neutrophil, count (Mean ± SD) 5.9 ± 5.23 6.69 ± 6.18 4.5 ± 2.44 0.0136
Lymphocyte, count (Mean ± SD) 2.09 ± 4.35 2.41 ± 5.43 1.54 ± 0.65 ns
Neutrophil, %WB (Mean ± SD) 65.9 ± 18.7 0.67 ± 0.2 0.64 ± 0.15 ns
Lymphocyte, %WB (Mean ± SD) 24.22 ± 15.84 0.23 ± 0.17 0.25 ± 0.13 ns
CRP (Mean ± SD) 19.97 ± 34.56 21.49 ± 34.25 17.31 ± 34.92 0.0024

sNS

0n (%) 9 (8.74) 5 (8.47) 4 (9.09) ns
1–2n (%) 26 (25.24) 19 (32.2) 7 (15.91) ns
≥ 3n (%) 68 (66.02) 35 (59.32) 33 (75) ns
sNS distribution
Any n (%) 94 (91.3) 54 (91.52) 40 (90.9) ns
Hyposmia n (%) 40 (38.83) 16 (27.12) 24 (55.54) 0.0047
Dysgeusia n (%) 48 (46.60) 20 (33.9) 28 (63.63) 0.0028
Auditory Dysfunction n (%) 2 (1.94) 0 (0) 2 (5.26) ns
Headache n (%) 40 (38.83) 16 (27.12) 24 (54.54) 0.0047
Confusion n (%) 23 (22.33) 12 (20.34) 11 (25) ns
Dizziness n (%) 27 (26.21) 11 (18.64) 16 (36.36) 0.0431
Numbness/Paresthesia n (%) 6 (5.8) 0 (0) 6 (13.63) 0.0035
Fatigue n (%) 33 (32.04) 22 (37.29) 11 (25) ns
Daytime Sleepiness n (%) 34 (33.01) 13 (22.03) 21 (47.72) 0.0061
Sleep Impairment n (%) 51 (49.51) 33 (55.93) 18 (40.9) ns
Muscle Ache n (%) 25 (24.27) 8 (13.56) 17 (38.63) 0.0033
Depression n (%) 39 (37.86) 19 (32.20) 20 (45.45) ns
Anxiety n (%) 34 (33.01) 18 (30.51) 16 (36.36) ns

List of abbreviations: n, Number of patients; SD, Standard Deviation; WBC, white blood cells; CRP, C-reactive protein; sNS, Subjective Neurological Symptoms; ns, Not Significant.